3-(3H-benzimidazol-5-yl)-5-[4-(fluoromethoxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;fluoroform
C18H11F7N4O2 — CID 162079065
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(3H-benzimidazol-5-yl)-5-[4-(fluoromethoxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;fluoroform
3-(3H-benzimidazol-5-yl)-5-[4-(fluoromethoxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;fluoroform (PubChem CID 162079065) has the molecular formula C18H11F7N4O2 and a molecular weight of 448.30 g/mol. Its IUPAC name is 3-(3H-benzimidazol-5-yl)-5-[4-(fluoromethoxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;fluoroform.
Molecular Properties
| Compound Name | 3-(3H-benzimidazol-5-yl)-5-[4-(fluoromethoxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;fluoroform |
|---|---|
| PubChem CID | 162079065 |
| Molecular Formula | C18H11F7N4O2 |
| Molecular Weight | 448.30 g/mol |
| Exact Mass | 448.08 |
| IUPAC Name | 3-(3H-benzimidazol-5-yl)-5-[4-(fluoromethoxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;fluoroform |
| SMILES | FC(F)F.FCOc1ccc(-c2nc(-c3ccc4nc[nH]c4c3)no2)cc1C(F)(F)F |
| InChI | InChI=1S/C17H10F4N4O2.CHF3/c18-7-26-14-4-2-10(5-11(14)17(19,20)21)16-24-15(25-27-16)9-1-3-12-13(6-9)23-8-22-12;2-1(3)4/h1-6,8H,7H2,(H,22,23);1H |
| InChIKey | ZCCAUZOHEVVICY-UHFFFAOYSA-N |
| XLogP | 5.78 |
| TPSA | 76.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 448.30 |
| LogP ≤ 5 | 5.78 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162079065 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.